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Abstract
Nitric oxide (NO) is believed to act as an intercellular signal that regulates synaptic plasticity in mature neurons. We now report that
NO also regulates the proliferation and differentiation of mouse brain neural progenitor cells (NPCs). Treatment of dissociated mouse
cortical neuroepithelial cluster cell cultures with the NO synthase inhibitor L-NAME or the NO scavenger hemoglobin increased cell
proliferation and decreased differentiation of the NPCs into neurons, whereas the NO donor sodium nitroprusside inhibited NPC
proliferation and increased neuronal differentiation. Brain-derived neurotrophic factor (BDNF) reduced NPC proliferation and increased the
expression of neuronal NO synthase (nNOS) in differentiating neurons. The stimulatory effect of BDNF on neuronal differentation of NPC
was blocked by L-NAME and hemoglobin, suggesting that NO produced by the latter cells inhibited proliferation and induced neuronal
differentiation of neighboring NPCs. A similar role for NO in regulating the switch of neural stem cells from proliferation to differentiation
in the adult brain is suggested by data showing that NO synthase inhibition enhances NPC proliferation and inhibits neuronal differentiation
in the subventricular zone of adult mice. These findings identify NO as a paracrine messenger stimulated by neurotrophin signaling in newly
generated neurons to control the proliferation and differentiation of NPC, a novel mechanism for the regulation of developmental and adult
neurogenesis.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
During embryonic development, neurons of the mamma-
lian cerebral cortex are generated from proliferating neuro-
epithelial cells in the telencephalic ventricular zone (VZ)
(Takahashi et al., 1995). Initially, cells in VZ are highly
proliferative, and as neurogenesis proceeds, some daughter
cells exit the cell cycle, migrate away from the VZ into the
cortical plate (CP), and differentiate into neurons (McCon-
nell, 1991, 1995; Takahashi et al., 1993, 1994). In the adult
brain, neural stem cells are concentrated in specific regions
of the CNS, including the subventricular zone of the cere-
bral cortex and the subgranular region of the hippocampal
dentate gyrus (Gage, 2000). Adult neural stem cells undergo
a similar transition from proliferation to differentiation, and
may provide a reservoir of cells capable of forming new
neurons that may eventually integrate into neuronal circuits
(Garcia-Verdugo et al., 1998).
Little is known about the cellular mechanisms that
determine when neural progenitor cell (NPC) prolifera-
tion stops and differentiation begins, although the signal-
ing molecules that regulate the transition of NPCs from
proliferation to differentiation are beginning to be iden-
tified, with several growth factors, including basic fibro-
blast growth factor, epidermal growth factor, brain-de-
rived neurotrophic factor (BDNF), and notch ligands
(Vescovi et al., 1993; Zigova et al., 1998; Benraiss et al.,
2001; Caldwell et al., 2001), differentially modulating
NPC proliferation and differentiation. BDNF and its
high-affinity receptor TrkB are widely expressed in the
developing and adult nervous system, and data suggest
that BDNF plays multiple roles in regulating the differ-
entiation, survival, and plasticity of several different pop-
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ulations of neurons (Lewin and Barde, 1996). The phe-
notypic abnormalities of CNS neurons in BDNF-deficient
mice indicate that BDNF is essential for normal brain
development. However, the cellular mechanism whereby
BDNF regulates NPC proliferation and differentiation
during brain development is largely unknown. Studies of
developing and adult neurons suggest that BDNF signal-
ing may require cooperative interactions with nitric oxide
(NO): BDNF and NO production appear to be coregu-
lated in rodent neocortical neurons (Xiong et al., 1999),
and BDNF regulates synaptic plasticity in the hippocam-
pus (Kang and Schuman, 1995, 1996; Figurov et al.,
1996) in a manner similar to that of NO (Shibuki and
Okada, 1991; Bohme et al., 1991). NO synthase (NOS)
oxidizes the guanidine nitrogen of L-arginine to form
citrulline and the short-lived free radical gas NO (Geller
and Billiar, 1998). There are three different isoforms of
NOS expressed in the brain, and their expression is re-
stricted to specific cell types: neuronal NOS (nNOS;
neurons), inducible NOS (iNOS; microglia and astro-
cytes), and endothelial NOS (eNOS; astrocytes and vas-
cular endothelial cells). NO may perform many functions
in the mature nervous system, including modulating syn-
aptic plasticity and cell survival (Holscher, 1997), and
may also promote neuronal death in neurodegenerative
disorders (Dawson and Dawson, 1998). In nonneural
cells, NO acts as an efficient antiproliferative agent by
suppressing DNA synthesis (Garg and Hassid, 1989; Ku-
zin et al., 1996). Recent findings suggest that NO can also
regulate cell proliferation and differentiation in neural
cells. NO may mediate nerve growth factor-induced
growth arrest and differentiation of PC12 cells (Peunova
and Enikolopov, 1995; Phung et al., 1999; Rialas et al.,
2000). The role of NO in brain development is unclear.
Neuronal NO synthase (nNOS) is transiently expressed in
the cerebral cortical plate and hippocampus in embryonic
rat brain during the period of peak cortical neurogenesis
(Bredt and Snyder, 1994). In addition, NO production is
regulated in an activity-dependent manner in the brain
during the period of developmental synaptogenesis (Ogil-
vie et al., 1995; Contestabile, 2000). Moreover, it was
recently reported that an NO donor can enhance neuro-
genesis following ischemic brain injury in adult rats
(Zhang et al., 2001). The signals that regulate the pro-
duction of NO during neural development are not known,
although the ability of BDNF to upregulate nNOS ex-
pression in several populations of CNS neurons in the
developing and adult CNS (Cellerino et al., 1999;
Klocker et al., 1999) suggests a potential role for this
neurotrophic factor. In the present study, we provide
evidence that NO acts as a paracrine messenger stimu-
lated by BDNF signaling in newly generated neurons to
control the proliferation and differentiation of NPCs, a
novel mechanism for the regulation of developmental and
adult neurogenesis.
Material and methods
Cell cultures and experimental treatments
Pregnant C57/B1-6J mice were euthanized on gestational
day 12 by cervical dislocation, and embryos were harvested
and their brains were removed. Meninges were removed
from the brain, and the cortical neuroepithelium was dis-
sected, collected in cold HBSS, and then transferred to
culture medium (DMEM/F12 supplemented with B27;
Gibco BRL). The tissues were gently triturated with a fire-
polished glass Pasteur pipette to yield small clusters of cells
consisting of 20–50 cells. Cell clusters were diluted with
the culture medium and plated onto poly-L-lysine-coated
glass coverslips or plastic culture dishes. The clusters were
plated at a density of approximately 200 per cm2. For pure
stem/progenitor cells cultures, we isolated fetal multipotent
neuroepithelial precursor (NEP) cells from E10.5 rat em-
bryos as described previously (Wu et al., 2002; Cai et al.,
2002). Truncated segments of the E10.5 embryos were
dissected and incubated in an enzyme solution containing
collagenase type I (1 mg/ml; Worthington Biochemical) and
dispase II (2 mg/ml; Roche) in Ca2/Mg2-free Hank’s
Balanced Salt Solution (Gibco/BRL) at room temperature
for approximately 10 min. The enzyme solution was then
replaced by NEP basal medium (Kalyani et al., 1997) with
10% chicken extract (CEE). The segments were gently
triturated with a pasteur pipette to release neural tubes from
surrounding somites and connective tissue. Isolated neural
tubes were dissociated by using trypsin–EDTA, and NEP
cells were grown in NEP basal medium with 10% CEE and
basic fibroblast growth factor (bFGF, 20 ng/ml; Peprotech).
Sodium nitroprusside (SNP), N(G)-nitro-L-arginine methyl
ester (L-NAME), and hemoglobin were prepared as 200–
500 stocks in culture medium immediately prior to use.
Recombinant human BDNF was purchased from Boeh-
ringer (Indianapolis, IN) and was stored at 80°C as 100-
g/ml stocks in PBS.
Evaluation of NPC proliferation and differentiation
Twenty-four hours after plating, cluster cell cultures
were exposed to experimental treatments for designated
time periods. Bromodeoxyuridine (BrdU) was then added to
cultures at a final concentration of 10 M, and 4 h later, the
cells were fixed in 4% paraformaldehyde in PBS, processed
for immunocytochemistry, and counterstained with PI to
label all the nuclei. To determine the proliferation index, we
acquired confocal images of 10–15 cell clusters per cover-
slip by using dual channels for BrdU immunostaining (488
nm excitation and 510 nm emission) and propidium iodide
(543 nm excitation and 590 nm emission). The BrdU- and
propidium iodide-positive cells are counted simultaneously
in each image. The proliferation index was calculated as the
percentage of BrdU-positive cells divided by the total num-
ber of the cells (propidium iodide-positive). A minimum of
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3 coverslips for each condition were used in each experi-
ment, and data presented are the results of 3–4 separate
experiments. To evaluate neuronal differentiation, cells
were immunostained with MAP2 and NeuN antibodies, and
immunoblot analysis of MAP2 protein levels was also per-
formed.
Evaluation of cell survival
After exposure to experimental treatments, cells were
fixed in 4% paraformaldehyde in PBS for 30 min at room
temperature washed with PBS, and then stained with the
DNA-binding dye Hoechst 33258. Coverslips were
mounted onto glass slides and examined under epifluores-
cence illumination by using a 40 objective lens. Cells
were considered “apoptotic” if their nuclear chromatin was
condensed or fragmented, whereas cells were considered
viable if their chromatin was diffusely and evenly distrib-
uted throughout the nucleus. To further confirm and detect
apoptotic DNA fragmentation, a TUNEL [terminal deoxy-
nucleotidyl transferase (TdT)-mediated deoxyuridine
triphosphate (dUTP)-biotin nick-end labeling] kit was used
(R&D Systems). Briefly, the cells were fixed with 4% para-
formaldehyde in PBS for 30 min and washed with PBS (pH
7.4). After blocking of endogenous peroxidases, the cells
were incubated at 37°C for 1 h in a reaction mixture con-
taining terminal transferase, biotinylated nucleotide
(dNTP), or PBS as control. Cells were then incubated in the
presence of streptavidin-conjugated horseradish peroxidase
(HRP) for 20 min at room temperature. After rinsing with
PBS, DNA strand breakage was visualized in the presence
of HRP substrate. The apoptotic cells exhibited a dark blue
nuclear staining. Approximately 10–15 clusters on each
coverslip were scored, 3 separate coverslips were assessed
for each condition in each experiment, and 3 separate ex-
periments were performed for both Hoechst 33258 staining
and TUNEL staining.
Histology and immunochemistry
Timed pregnant C57BI/6J mice at embryonic day (E) 12,
E16 were sacrificed by cervical dislocation, embryos were
removed and decapitated, and heads of fetal mice were fixed
in 4% paraformaldehyde in PBS overnight. Brains were
cryoprotected by immersing in 25% sucrose in PBS and
embedded in Tissue-Tek (Sakura, Torrance, CA), and cry-
ostat sections were cut in the coronal plane at a thickness of
10–40 m. Sections were transferred to Superfrost Plus
slides (Fisher Scientific, Springfield, NJ), dried, and stored
at 20°C or collected in PBS for staining. Brain sections or
coverslips containing cultured cells were processed for im-
munocytochemistry. The primary antibodies used in this
study and their dilutions were: mouse anti-nestin IgG1
(1:200, Chemicon); mouse ant-E-NCAM IgM (1:50); rabbit
anti-Sox2 IgG (1:2000); mouse anti MAP2 IgG1 (1:200,
Sigma); mouse anti-NeuN IgG1 (1:200, Chemicon), rabbit
anti-GFAP IgG (1:1000, Chemicon); rabbit anti-nNOS IgG
(1:1000, BD Transduction Laboratories); mouse anti-BrdU
IgG1 (1:100, Becton-Dickson); rabbit anti-TrkB IgG
(1:1000, Santa Cruz); and rabbit anti-BDNF IgG (1:1000,
Santa Cruz). Secondary antibodies used and their dilutions
were: fluorescein isothiocyanate (FITC)-conjugated goat
anti- mouse IgG1 (1:100, South Biotechnology Associate,
AL) (nestin, MAP2, and BrdU); rhodamine- conjugated
goat anti-mouse IgG1 (1:100, South Biotechnology Associ-
ate, AL) (MAP2); FITC-conjugated goat anti-mouse IgM
(1:100, Jackson Immunoresearch, PA) (E-NCAM); FITC-
conjugated donkey anti-rabbit IgG (1:100, Jackson Immu-
noresearch, PA) (GFAP, nNOS, TrkB, BDNF).
For immunofluorescence cytochemistry, coverslips from
cultures that had been fixed in 4% paraformaldehyde in PBS
for 30 min or sections were washed in PBS, permeabilized,
and preincubated with the blocking solution (0.2% Triton
X-100, 10% normal goat serum) in PBS for 30 min, and
then incubated overnight with a primary antibody diluted in
the same blocking solution at 4°C. Cells were washed with
PBS and incubated with appropriate secondary antibodies
diluted in same blocking solutions for 2 h at room temper-
ature. Sections or coverslips were counterstained with pro-
pidium iodide (PI) (0.02% PI and 1% Rnase in PBS) for 10
min; they were then washed with PBS and mounted on
microscope slides by using a fluorescence anti- fade me-
dium (Vector Lab, CA).
For the avidin-biotin-HRP methods (ABC Kit, Vector
Lab, CA), BrdU, nNOS, TrkB, and BDNF immunohisto-
chemistry were performed on free-floating sections. Instead
of mounting on slides, frozen sections (40 m) were col-
lected in PBS and washed several times in PBS. Sections
were then incubated in 1% H2O2 for 30 min to quench
endogenous peroxidase activity. After rinsing with PBS,
sections were incubated overnight with primary antibodies
at 4°C, then washed in PBS and further processed by using
a Vector ABC Elite Kit (Vector Labs). The sections were
further processed by incubation in a solution containing
0.035% diaminobenzidine and 0.01% H2O2. The developed
sections were mounted on Superfrost Plus slides and dehy-
drated in a graded ethanol series, and immersed in 100%
Xylene for 15 min. Sections were then coverslipped in
Permount medium (Fisher Scientific, NJ). For BrdU immu-
nohistochemistry, similar procedures were followed, except
that the sections were denatured by incubating in a solution
of 2 N HCl for 45 min before the primary antibody was
added.
RT-PCR analysis
Total RNA was isolated directly from freshly dissected
mouse E9 neural tubes and E12, E15, and E17 cerebral
cortex with Trizol (Invitrogen), a modification of the gua-
nine isothiocyanate-phenol-chloroform extraction method.
cDNA was synthesized by using 100 ng total RNA in a 20-
l reaction with superscript II (Invitrogen) and oligo (dT)
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12–18 (Invitrogen). One microliter of RNase H (Invitrogen)
was added to each reaction tube, and the tubes were incu-
bated for 20 min at 37°C before proceeding to the RT-PCR
analysis.
For PCR amplification 0.5 l cDNA template was used
in a 50-l reaction volume with the RedTaq DNA polymer-
ase (Sigma). The cycling parameters were: 94°C, 1 min;
55°C, 1 min; 72°C, 1 min, for 30 cycles. The PCR cycles
were preceded by an initial denaturation of 3 min at 94°C
and followed by a final extension of 10 min at 72°C. Primer
sequences were as follows: TrkB forward: 5-TGA AAC
AAG CCA CAC ACA G-3; TrkB reverse: 5-AAT CAC
CAC CAC GGC ATA G-3; the length of the PCR product
was 592 bp. G3PDH forward: 5-TGA TGG GTG TGA
ACC ACG AG-3; G3PDH reverse: 5-CTC CTG TTG
TTA TGG GGT CTG- 3; the length of the PCR product
was 758 bp.
Immunoblot analysis
After experimental treatments, cells were solubilized in
SDS-PAGE sample buffer, and proteins in cell lysates were
Fig. 1. Neuronal nitric oxide synthase (nNOS) is absent from proliferating neural stem cells and is progressively upregulated in differentiating neuronal
progeny during embryonic and postnatal development. (A) nNOS immunoreactivity overlaps with that of MAP2, a marker of differentiated neurons. Both
nNOS and MAP2 immunoreactivities are absent in NPC of the ventricular zone (VZ), present in the postmitotic cells of developing zones including cortical
plate (CP) neurons and the presumptive migrating neuronal cells in the intermediate zone (IZ) at embryonic day 16 (E16). The section shown at the left is
stained with cresyl violet, the middle panel shows an adjacent section stained with nNOS antibody, and the panels at the right show high magnification views
of cells in the corresponding cortical regions. Scale bar, 100 m. (B) Immunoblot analysis showing a progressive increase of nNOS protein levels in the
developing cerebral cortex. In contrast, iNOS protein level shows a low and constant expression pattern during development. Proteins in cortical homogenates
(50 g/lane) were subjected to immunoblot analysis by using antibodies against nNOS or iNOS. The blots were stripped and reprobed by using an antibody
against -tubulin, which demonstrated equal protein loading. (C) Results of densitometric analysis of blots of samples from four different mice of each age
(mean and SD).
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resolved in a SDS-polyacrylamide gel (7.5–12% acryl-
amide; 50 g protein per lane) and electrophoretically trans-
ferred to a nitrocellulose membrane. Membranes were
blocked with 4% nonfat milk in TBST and then incubated
for 2 h in the presence of primary antibody. Membranes
were washed and then incubated for 1 h in the presence of
a 1:5000 dilution of secondary antibody (anti-mouse or
anti-rabbit IgG) conjugated to horseradish peroxidase. Re-
action products were visualized by using an enhanced
chemiluminescence (ECL) Western Blot Detection Kit
(Amersham Pharmacia Biotech). The primary antibodies
included a rabbit polyclonal antibody against nNOS
(1:1000, BD Transduction Laboratories), a rabbit polyclonal
antibody against iNOS (1:1000, BD Transduction Labora-
tories), a rabbit polyclonal antibody against beta-tubulin
(1:5000, Sigma), mouse monoclonal antibody against
MAP2 (1:500, Sigma), and a rabbit polyclonal antibody
against TrkB (1:2000, Santa Cruz).
In vivo studies
Mice were anesthetized by using isofluorane and
mounted in a stereotaxic apparatus. A sagittal incision was
made through the skin along the midline of the head, and a
hole was drilled in the skull at a position 0.2 mm posterior
and 1.2 mm lateral (right) to bregma. A Hamilton syringe
containing L-NAME (50 mM solution in PBS) or PBS was
positioned over the hole, and the needle tip was lowered into
Fig. 2. Characterization of cultured E12 cortical neural clusters growing in absence of exogenous growth factors. (A) Sections of E12 mouse cortex stained
with propidium iodide (PI) to label the nuclei of all cells, or with antibodies against nestin and E-NCAM. Scale bar, 50 m. (B, C). Cells were stained with
nestin, MAP2, E-NCAM, GFAP, and nNOS antibodies after 9 h (B) or 72 h (C) in culture. Cells were counterstained with propidium iodide to label nuclei
(red). Note the increase in numbers of cells immunoreactive with antibodies against neuronal antigens (nNOS, E-NCAM and MAP-2) with increasing time
in culture. (D) Double immunostaining of MAP2 (red) and nNOS (green) after 72 h in culture. Scale bar, 20 m.
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the lateral ventrical (2.0 mm below the brain surface). One
microliter of solution was injected (5 mice received L-
NAME and 5 mice received PBS). In order to determine
whether the proliferation potential of NPC in VZ was af-
fected by the nNOS inhibitor, 24 h after stereotaxic injection
of L-NAME or PBS, mice were given two intraperitoneal
injections of BrdU (50 mg/kg) separated by 2 h. This pro-
tocol was used to ensure that BrdU-labeled cells did not
have time to migrate away from the SVZ, which would
complicate the quantification. Using this protocol, all BrdU-
labeled cells are in S phase and are located in SVZ. Assum-
ing that L-NAME and PBS injections did not change the
total number of NPC in the SVZ, the number of BrdU-
labeled cells in SVZ provides a reliable estimate of the
proliferation potential of the NPC. Two hours after the
second BrdU injection, the mice were anesthetized by in-
halation of isoflurane and were transcardially perfused with
phosphate-buffered saline followed by 4% paraformalde-
hyde in phosphate- buffered saline (pH 7.4). Brains were
postfixed overnight, cryoprotected, frozen, and microtome-
sectioned coronally at 20 m thickness. Every fourth sec-
tion in the forebrain was processed for BrdU immunohis-
tochemistry, and all BrdU-positive cells in the SVZ sur-
rounding the third ventricle in each section were counted in
a total of 10 sections for each brain. The values presented
represent the total number of BrdU-positive cells in 10
sections for each brain.
Statistics
All data are presented as mean  SD. Comparisons
between control and treatment groups were performed by
using Student’s unpaired t test or ANOVA when appropri-
ate. A value of P  0.05 was considered to be statistically
significant.
Results
nNOS production progressively increases during cortical
development in vivo and in cell culture
In the mammalian cortex, the majority of neurons are
generated from the ventricular zone (VZ) adjacent to the
lateral ventricles. The newly generated neurons migrate
outward through the intermediate zone and into the cortical
plate, where they form the six layers of the adult cortex.
Cresyl violet staining of coronal sections of E16 mouse
somatosensory cortex reveals the typical developing zones
(Fig. 1A), and nNOS immunostaining reveals the localiza-
tion of nNOS protein in postmitotic neurons in the CP and
in the intermediate zone (IZ), with little or no nNOS being
present in proliferative cells of the VZ (Fig. 1A). The nNOS
immunoreactivity is similar to that of MAP2, a marker of
differentiated neurons, suggesting that nNOS expression
occurs as the neurons differentiate. Immunoblot analysis of
cortical homogenates showed that the level of nNOS was
very low at E11, and then progressively increased from E13
through postnatal day 2 (Fig. 1B and C). These results are
consistent with the previously described pattern of nNOS
gene expression in the developing rat cerebral cortex (Bredt
and Snyder, 1994). In contrast to the dramatic developmen-
tal increase in nNOS levels, iNOS protein levels remained
low and constant during cortical development (Fig. 1B and C).
Because NO is a diffusible intercellular messenger, we
sought to determine whether NO produced by differentiat-
ing neurons might influence the behavior of neighboring
cortical neural stem cells. To study the effects of NO on the
process of NPC differentiation under well-defined experi-
mental conditions, we employed neural cluster cell cultures
established from the cortical epithelium of E12 mice, a time
when the first postmitotic neurons of the cortex are begin-
ning to differentiate (Ghosh and Greenberg, 1995). At E12,
the cerebral wall consists mainly of the VZ and a very thin
layer of differentiating cells (preplate layer) (Luskin and
Shatz, 1985), located adjacent to the VZ as indicated by
propidium iodide (PI) staining in Fig. 2A. In order to char-
acterize the phenotypes of the cells at this stage of cortical
development, we employed antibodies against the interme-
diate filament protein nestin (Lendahl et al., 1990) and the
transcription factor sox2 (Uwanogho et al., 1995; Zappone
et al., 2000), which are markers of NPC, and an antibody
against E-NCAM, a cell surface protein expressed by neu-
ron-restricted progenitor cells and differentiated neurons
(Mayer-Proschel et al., 1997; Mujtaba et al., 1999). The vast
majority of cells in the VZ express nestin and sox2 and
some of them also express E-NCAM (Fig. 2A and data not
shown). Cells in the differentiated preplate layer were
heavily labeled with the E-NCAM antibody, but were not
immunoreactive with nestin (Fig. 2A). Therefore, E12 is a
time when the first postmitotic neurons of the cortex are
beginning to differentiate, and cells in VZ at this stage are
a combination of restricted neuronal progenitors and NPC.
We next characterized the phenotypes of cells in the
cluster cell cultures using antibodies against nestin,
E-NCAM, MAP2 (a neuronal microtubule-associated pro-
tein), GFAP (an astrocytic intermediate filament protein),
and nNOS. Nine hours after plating, more than 80% of the
cells were nestin-positive, only 9% were MAP2-positive,
and none expressed GFAP (Fig. 2B; Table 1). More than
90% of the cells exhibited an undifferentiated morphology,
although a few cells in most clusters elaborated short pro-
cesses and were MAP2-positive. There was a progressive
Table 1
Percentage  SD
Nestin E-NCAM MAP2 nNOS GFAP
9 h 82.8  7.2 50.3  7.5 8.7  3.0 5.4  2.5 0
24 h 70.2  1.4 68.4  2.0 18.6  5.8 14.4  3.8 0
72 h 62.0  8.5 91.2  2.5 32.0  6.4 25.2  4.3 1.9  1.1
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decrease in the percentage of cells that were nestin-positive
and a corresponding increase in the percentage of cells that
were MAP2-positive through 72 h in culture (Fig. 2B and C;
Table 1). The percentage of cells expressing E-NCAM in-
creased from 50.3% at 9 h to 91% at the 72-h time point
(Table 1). By 72 h in culture, many cells exhibited long
processes and expressed both MAP2 and E-NCAM (Fig.
2C). GFAP-positive cells were extremely rare, comprising
less than 2% of the cells at 72 h in culture (Fig. 2C; Table
1). These results indicate that the majority of NPC in these
cortical cluster cell cultures differentiate into neurons.
We next characterized the developmental regulation of
nNOS expression in cortical cluster cell cultures. The num-
ber of nNOS imunoreactive cells and the level of nNOS
protein was very low at the time of plating and then in-
creased through culture day 3 (Figs. 2 and 4; Table 1).
Double immunostaining of cluster cell cultures with MAP2
and nNOS revealed that nNOS immunoreactivity is present
at high levels in cells with a neuronal phenotype (MAP2-
positive cells with neurites) and at undetectable or very low
levels in cells that lacked MAP2 (Fig. 2D). The latter results
are consistent with the immunostaining pattern in vivo (Fig.
1A) and demonstrate that nNOS levels increase in neurons
as they differentiate. Neither iNOS nor eNOS was detected
by immunostaining or immunoblotting in the cluster cell
cultures (data not shown), consistent with lack of microglia
and vascular endothelial cells in these cultures.
BDNF enhances nNOS production during differentiation
of embryonic neural progenitor cells
Although BDNF and NO have been shown to exert
similar effects on synaptic plasticity and neuronal differen-
tiation (Xiong et al., 1999; Kang and Schuman, 1995, 1996;
Figurov et al., 1996; Shibuki and Okada, 1991; Bohme et
al., 1991), it is not known if they act in the same or different
signaling pathways. To determine whether BDNF can mod-
ulate the production of NO during neurogenesis, NPC clus-
ter cultures were treated with BDNF for 2 days, and the
percentages of nNOS-positive cells and nNOS level were
quantified. There was a two-fold increase in the percentage
of nNOS immunoreactive cells (Fig. 3A and B). Nearly all
of the nNOS-positive cells were MAP2-positive (data not
shown). Immunoblot analysis confirmed that levels of
nNOS were greatly increased in cluster cell cultures treated
with BDNF, with physiologically relevant concentrations of
10–50 ng/ml being effective (Fig. 3C and D). In order to
determine whether endogenous BDNF signaling contributed
to differentiation of NPC into neurons and nitric oxide
signaling, we treated NPC cultures with a BDNF blocking
antibody previously shown to neutralize endogenous BDNF
signaling (Duan et al., 2001). Levels of nNOS were signif-
icantly decreased in NPC cultures at each culture time point
examined from 1 to 4 days in culture (Fig. 4), demonstrating
a role for endogenous BDNF in nNOS production.
Nitric oxide promotes the switch of NPC from
proliferation to differentiation
BDNF was reported to induce differentiation and matu-
ration of hippocampal and cortical NPC into a neuronal
phenotype (Maisonpierre et al., 1990; Ghosh and Green-
berg, 1995) and can also enhance adult neurogenesis (Ben-
raiss et al., 2001; Pencea et al., 2001). The ability of BDNF
to upregulate the expression of nNOS in NPC suggested a
role for nitric oxide signaling in the regulation of neurogen-
esis. We first determined whether NO can directly affect the
switch of NPC from proliferation to differentiation by quan-
tifying the proliferation rate of NPC following manipula-
tions that either induce or inhibit NO production. Cultures
were exposed to the nitric oxide donor sodium nitroprusside
(SNP), the NOS inhibitor, N--nitro-L-arginine methylester
(L-NAME), or the nitric oxide scavenger reduced hemoglo-
bin, and cell proliferation rate was determined. Twenty-four
hours after plating, the cells were treated with SNP, L-
NAME, or hemoglobin for 24 h, pulse-labeled with BrdU
for 4 h, and then fixed and immunostained with BrdU
antibody. In control cultures, the proliferation index for 4 h
BrdU incorporation is approximately 35%. In order to more
clearly show the effect of each treatment, and at the same
time reduce variability, we presented proliferation index
after different treatments as a percentage of that of untreated
control cultures. Exposure of cluster cell cultures to SNP
significantly decreased the number of BrdU-positive cells in
a concentration-dependent manner (Fig. 5A and B). Be-
cause it had been previously suggested that BDNF can
promote neuronal differentiation (Benraiss et al., 2001; Lee
et al., 2002), we compared the effects of SNP and BDNF on
NPC proliferation and neuronal differentiation. At a con-
centration of 40 M, the proliferation index was approxi-
mately 20%, and SNP inhibited cell proliferation by 40%, a
magnitude of inhibition similar to that of cells exposed to
BDNF (Fig. 5A and B). Because nNOS is not expressed in
proliferating cells in the VZ, but is present in differentiating
neurons (Fig. 1), we designed experiments to establish
whether NO produced by differentiating neurons acted in a
paracrine manner to regulate the proliferation and differen-
tiation of NPC. First, we quantified NPC proliferation in
cultures in which the NO scavenger hemoglobin was added
to the medium. Hemoglobin abolished the inhibitory effect
of SNP on NPC proliferation (Fig. 5C). Moreover, hemo-
globin itself significantly increased NPCs proliferation, sug-
gesting a role for intercellular NO signaling in controlling
the basal rate of NPC proliferation (Fig. 5C). A role for
endogenous NO production in regulating NPC proliferation
was further supported by data showing that exposure of
cells to the NOS inhibitor L-NAME significantly increases
NPC proliferation (Fig. 5C).
A decrease in the proliferation index is usually accom-
panied by a corresponding increase in cell differentiation.
We therefore determined the percentages of cells expressing
MAP2 and NeuN, markers of neurons. After 48 h of treat-
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Fig. 3. BDNF increases nNOS levels in neural progenitor cells. (A) Confocal images of cultured neuroepithelial cell clusters showing nNOS-positive cells
after 48 h of treatment with either BDNF (30 ng/ml) or saline control (Con). (B) The percentage of nNOS-positive cells was increased significantly with
BDNF treatment. Values are the mean and SD from three separate experiments (**, P 0.01; paired t test). (C) Immunoblots of proteins (50 g/lane) probed
with an nNOS antibody documenting a marked increase in the level of nNOS protein in BDNF-treated cultures and the blots were reprobed with -tubulin
to show relative amounts of total protein in each lane. (D) Results of densitometric analyis of immunoblots. Values of nNOS protein were normalized to the
-tubulin in the same lane. Values are expressed as fold change compared with the nNOS protein level in untreated control cultures. Values are the mean
and SD of at least three different cultures per condition. *, P  0.01 compared with the value for control cultures.
Fig. 4. A BDNF neutralizing antibody (BDNF AB) reduces the expression of nNOS in neural progenitor cells. (A) NPC were cultured in absence or presence
of BDNF neutralizing antibody (1 g/ml) for the indicated number of days and nNOS protein levels were determined by immunoblot analysis (50 g
protein/lane). Densitometric analysis of samples from three different experiments (B) revealed significant decreases in nNOS protein levels at each time point
(mean and SD; *, P  0.01).
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ment with SNP or BDNF, the cells were fixed and immu-
nostained MAP2 or NeuN antibodies and counterstained
with propidium iodide to label all nuclei. Cell lysates from
additional cultures were subjected to immunoblot analysis
by using a MAP2 antibody. There was a marked increase in
the number of MAP2- and NeuN-positive cells (Fig. 6A, D,
and E) and in the level of MAP2 protein (Fig. 6B and C) in
BDNF- and SNP-treated cells compared with vehicle-
treated control cells. These findings indicate that both NO
and BDNF promote a developmental switch of NPCs from
a proliferative state to differentiation into neurons.
BDNF is a well-known neurotrophic factor promoting
neuronal survival (Lewin and Barde, 1996), and SNP was
previously reported to induce NPC cell death in a dose-
dependent manner (Cheng et al., 2001). To test whether a
BDNF blocking antibody and 40 M SNP (the maximal
dosage we used in this study) can cause cell death, we
exposed E12 neural cluster cultures to BDNF antibody or
SNP and quantified the percentage of cells exhibiting
apoptotic nuclear changes (nuclear chromatin condensation/
fragmentation and DNA strand breaks) using Hoechst
33258 and TUNEL staining (Fig. 7). The percentages of cell
death quantified using each method were essentially iden-
tical. The percentage of cells with apoptotic nuclei in con-
trol cultures (5%) was similar to that in cultures treated with
BDNF antibody or SNP, indicating that BDNF antibody and
SNP did not kill cells. The latter results are consistent with
our previous studies showing that essentially no cell death
occurred in cultures of a NPC line exposed to less than 100
M SNP (Cheng et al., 2001).
Nitric oxide mediates the neurogenic action of BDNF
To determine whether BDNF signaling and NO produc-
tion affect the transition of NPCs from proliferation to
differentiation in vivo, we first evaluated the cellular local-
ization of BDNF and its high-affinity receptor TrkB in the
developing cerebral cortex. TrkB immunoreactivity was
present in cells throughout the developing cortex, including
NPC in the VZ, which exhibited TrkB immunoreactivity in
their periphery, consistent with localization in the plasma
membrane (Fig. 8A). TrkB protein can exist as a full-length
functional receptor or as a truncated protein; the truncated
trkB receptor can be soluble or membrane-associated (Es-
candon et al., 1994). Immunoblot analysis of cortical ho-
mogenates from mice of increasing ages from E11 to adult
revealed that levels of full-length TrkB were already high at
E11, were further increased at P2, and then remained at a
similar level in the adult cortex (Fig. 8C). Levels of trun-
cated TrkB were very low at E11, were increased markedly
by P2, and remained elevated in the adult cortex (Fig. 8C),
suggesting that NPC in the developing neocortex contain
functional TrkB. The presence of TrkB in NPC in develop-
ing brains was further confirmed by RT PCR, showing that
TrkB mRNA is present in cells of the E12 mice cerebral
wall. In contrast, cells located in the IZ and CP exhibited
BDNF immunoreactivity, whereas NPC in the VZ do not
(Fig. 8B). These findings suggest that VZ NPC are capable
of responding to BDNF, but do not themselves produce
BDNF.
Because nNOS and BDNF have similar expression pat-
terns in the developing brain, and because NO and BDNF
have similar effects on NPC proliferation and differentia-
tion, we sought an understanding of how these two mole-
cules might interact to regulate the progression of NPC from
proliferation to differentiation. We tested the hypothesis
that upregulation of nNOS expression and nitric oxide sig-
naling in newly generated neurons mediates the stimulation
of the switch from proliferation to differentiation by BDNF.
We found that the ability of BDNF to suppress NPC pro-
liferation was abolished in cultures treated with either the
NOS inhibitor L- NAME and the NO scavenger hemoglobin
(Fig. 9). Moreover, the ability of BDNF to induce differen-
tiation of NPC into neurons was blocked by treatment of
cultures with L-NAME or hemoglobin (data not shown).
These data identified a novel positive feedback loop in
which BDNF enhances nNOS expression in differentiating
neurons, and the differentiated neurons, in turn, produce NO
which diffuses to NPCs wherein it inhibits their prolifera-
tion and enhances their differentiation into neurons. To
further support the existence of such a positive feedback
loop, we isolated fetal neuroepithelial progenitor (NEP)
Fig. 5. Nitric oxide mediates suppression of NPC proliferation and stimulation of neurogenesis by BDNF. (A, B). Incorporation of BrdU into neural progenitor
cells is attenuated by the NO donor sodium nitroprusside (SNP) and by BDNF. (A) After 48 h of treatment with SNP (40 M) or BDNF (20 ng/ml) beginning
on culture day 1, the cells were pulsed with BrdU for 4 h and then immunostained with a BrdU antibody (green) and counterstained with propidium iodide
to label all the nuclei (red). The micrographs at the left are transmitted light images of the same microscope fields. Scale bar, 20 m. (B) The proliferation
index was calculated by counting BrdU-positive cells and total cells, and is expressed as a percentage of the proliferation index in control cultures. Values
are the mean and SD of determinations made in three separate experiments (30 clusters assessed in each experiment). *, P  0.05; **, P  0.01 compared
with the control (con) value (ANOVA with Scheffe post-hoc tests). (C) The NO scavenger hemoglobin (HB) abolishes the inhibitory effects of SNP (40 M)
on NPC proliferation, and both hemoglobin and the NOS inhibitor L-NAME enhance NPC proliferation. Values are the means and SD of four separate
experiments. *, P  0.05, **, P  0.01 compared with the control value (ANOVA with Scheffe post-hoc tests).
Fig. 6. Nitric oxide and BDNF stimulate the transition of NPC from proliferation to differentiation in embryonic cortical cell cultures. E12 mouse
neuroepithelial cells were grown in presence of 25 ng/ml BDNF or SNP (20 or 40 M) or were left untreated (Con). After 48 h of treatment with SNP or
BDNF, the cells were fixed and immunostained with propidium iodide to label all the nuclei (red), and with antibodies against either MAP2 (A) or NeuN
(D). (B, C) Cell lysates from additional cultures were subjected to immunoblot analysis using a MAP2 antibody. (E) Quantification of NeuN-positive cells
(mean and SD of 4 separate cultures). There was a marked increase in the number of MAP2 positive cells (A) and in the level of MAP2 protein in BDNF-
and SNP-treated cells compared with vehicle-treated control cells. *, P  0.05; *, P  0.01 compared with the control value.
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cells from E10.5 rat embryos as described previously (Wu et
al., 2002; Cai et al., 2002). These NEP cells were previously
characterized to be multipotent neural stem cells that do not
express early differentiation markers (Cai et al., 2002);
therefore, they are pure neural stem cell cultures without
MAP2/nNOS postmitotic neurons. We found that NEP
cell proliferation ability is not affected by BDNF (Fig. 9).
Collectively, these findings suggested essential roles for NO
production and paracrine signaling in BDNF-mediated NPC
transition from proliferation to differentiation.
Nitric oxide regulates neural progenitor cell proliferation
and differentiation of adult NPCs in vivo
To determine whether NO has a similar function in
regulating NPC proliferation and differentiation in adult
brains in vivo, we administered L-NAME into the right
lateral ventricle of adult mice and then labeled proliferating
cells with BrdU. Numbers of BrdU-positive cells were sig-
nificantly increased in the subventricular zone of the right
cerebral hemisphere of mice given L-NAME compared with
the contralateral hemisphere, and to both hemispheres of
control mice receiving a saline infusion in the right lateral
ventricle (Fig. 10). It indicated that NO plays a similar role
in arresting cell cycle, promoting a transition from prolif-
erative precursors to postmitotic cells. Thus, as was the case
in embryonic cortical development, NO plays an important
signaling role in the progression of adult neurogenesis.
Discussion
In the present study, we observed that the nitric oxide donor
SNP and BDNF can each trigger a switch of cerebral NPC
from proliferation to differentiation. BDNF enhanced the
expression of nNOS in newly generated neurons. A similar
effect of BDNF on mature cortical neurons in culture was
reported by Xiong et al. (1999), suggesting maintenance of
this BDNF signaling mechanism in the mature nervous
system. Moreover, we showed that NO is an essential me-
diator of BDNF’s ability to regulate NPC proliferation and
differentiation. Collectively, these findings suggest a novel
role for neuron-derived NO in triggering a switch of cere-
bral neural progenitor cells from proliferation to differenti-
ation in the developing and adult mammalian brain. A
paracrine action of NO produced by newly generated neu-
rons that express nNOS and acting on neighboring NPC is
suggested by the ability of the extracellular nitric oxide
scavenger hemoglobin and an nNOS inhibitor to maintain
NPCs in a proliferative state, thereby suppressing neuronal
differentiation. Importantly, our data show that paracrine
NO sigaling is an essential mediator of the BDNF-induced
transition of NPC from proliferation to differentiation. The
effect of endogenous NO in suppressing NPC proliferation
and promoting neuronal differentiation of NPC progeny was
robust, suggesting that, although other molecules may also
regulate these processes, our data suggest that the BDNF-
NO-positive feedback loop is an important pathway regu-
lating embryonic and adult neurogenesis. These findings
provide a basis for the formulation of a model for regulation
of NPC proliferation and differentiation by NO in which
NPC in the ventricular zone lack nNOS, but are responsive
to NO produced by neighboring neuronal progeny. In this
way, nitric oxide produced by newly generated neurons
provides a feedback signal to NPC that inhibits their pro-
liferation and promotes differentiation along neuronal lin-
eages. This model fits the temporal changes and cellular
localization of nNOS during brain development in that
nNOS is expressed in newly generated neurons in the em-
bryonic cortical plate, but is absent from proliferating NPC
in the subventricular zone. Consistent with our analysis of
the developing mouse cerebral cortex, it was previously
shown that nNOS is expressed in migrating cells with a
neuronal phenotype in the marginal and intermediate zones
of the developing rat cerebral cortex and is absent from glial
cells (Santacana et al., 1998). When taken together with our
observation that nNOS expression is rapidly upregulated in
neuronal progeny of NPC during in vitroneurogenesis, the
available data suggest an important role for NO produced by
differentiating neuronal neighbors in regulating the prolif-
eration and differentiation of NPC.
We found that BDNF enhances nNOS expression in
developing cortical NPC. Previous studies have shown that
BDNF and nitric oxide share other biological actions on
neurons. For example, both BDNF and nitric oxide enhance
synaptic plasticity in the adult hippocampus and promote
neuronal survival during development (Bredt and Snyder,
1994; Schuman and Madison, 1994; Garthwaite and Boul-
ton, 1995; Lo, 1995; Stoop and Poo, 1996). Endogenous
nitric oxide regulates BDNF production, and conversely,
BDNF induces nNOS gene expression and nitric oxide
production in cultured neocortical neurons (Xiong et al.,
1999). However, a role for nitric oxide in mediating phys-
iological actions of BDNF had not previously been estab-
lished. Our data suggest that BDNF may facilitate NPC
transition from proliferation to differentiation by upregulat-
ing the expression of nNOS in differentiating neurons,
thereby providing them with the ability to produce nitric
oxide. NO is a diffusible gas with an effective signaling
range of approximately 150–300 m. We found that nitric
oxide generated by nNOS-expressing neurons can affect the
fate of neighboring NPC, causing NPC to exit the cell cycle,
consistent with an antiproliferative effect of nitric oxide on
in nonneuronal cells (Garg and Hassid, 1989; Lepoivre et
al., 1990). Therefore, NO and BDNF appear to function in
a positive feedback loop to stimulate the progress of neu-
rogenesis. Moreover, our data show that, in pure neural stem
cell cultures (E10.5 NEP cells) that do not express early
differentiation markers (Cai et al., 2002), BDNF does not
affect cell proliferation even though Trk B is expressed in
the cells. Because we found that an extracellular nitric oxide
scavenger can block the effect of BDNF in inhibiting the
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NPC proliferation in E12 neural cluster cultures, nitric ox-
ide appears to be an essential mediator of BDNF-induced
switch of neural progenitors from proliferation to differen-
tiation. Our immunostaining results show that Trk B is
present in NPC in the ventricular zone and in neurons in the
postmitotic zones, whereas both BDNF and nNOS are
present in the postmitotic neurons, but absent from NPC.
Thus, it appears that both BDNF and NO exert their effects
on NPC indirectly. BDNF and nitric oxide may act at
multiple stages of cerebral cortical development, affecting
Fig. 7. SNP and a BDNF neutralizing antibody do not cause cell death in NPC cultures. E12 mouse cortical NPC were grown in presence of a BDNF
neutralizing antibody (BDNFAB) or SNP (40 M) or were left untreated (Con). After 48 h of treatment with SNP or BDNFAB, the cells were fixed. And
stained with either Hoechst 33258 or TUNEL to identify apoptotic cells. Hoechst-stained cells were considered apoptotic if their nuclear chromatin was
condensed or fragmented (A, arrows), whereas cells were considered viable if their chromatin was diffusely and evenly distributed throughout the nucleus.
TUNEL-stained cells exhibited dark blue nuclear staining (B, arrows). There was no significant increase in apoptotic cells in cultures treated with either SNP
or BDNFAB (n  3).
Fig. 8. Cellular localization and developmental expression of TrkB and BDNF during cortical development. (A, B) Immunostaining of E16 mouse cortex with
antibodies against TrkB (A) and BDNF (B). Scale bar, 100 m. (C) Immunoblot analysis of full-length (FL) and truncated (T) forms of TrkB in homogenates
of cerebral cortex from mice of the indicated ages.
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the proliferation of NPC, and the differentiation/migration
and survival of their neuronal progeny. The specific effect
of nitric oxide may depend on its concentration and there-
fore the location of the cells within the presumptive gradient
of nitric oxide concentrations established by the spatial
gradient of cells expressing nNOS.
BDNF levels and neurogenesis are increased in adult rats
and mice maintained in complex environments (Young et
al., 1999) or subjected to dietary restriction (Lee et al.,
2002), two environmental factors that also enhance learning
and memory. Previous findings suggest that nitric oxide
signaling plays important roles in regulating neurite out-
growth and synaptogenesis in the developing brain, and in
long-lasting changes in the structure and function of neuro-
Fig. 9. (A) Hemoglobin and L-NAME abolish the inhibitory effect of BDNF (30 ng/ml) on NPC proliferation (cells were treated for 48 h). Values are the
means and SD of four separate experiments. **, P  0.01 compared with each of the other values. (B) Photomicrograph of E10.5 multipotent NEP cells.
(C) BDNF did not promote the transition of E10.5 NEP cells from proliferation to differentiation. Cultured NEP cells were administrated 10 M BrdU for
4 h after 24 or 72 h in the absence or presence of BDNF (25 ng/ml), and then fixed and processed for BrdU immunocytochemistry.
Fig. 10. Intraventricular administration of a NOS inhibitor promotes neural stem cell proliferation in the sub-ventricular zone of adult mice. L-NAME or PBS
was infused into the right lateral ventricle. The injected mice were kept alive for 24 h, then BrdU (50 g/g body weight) was injected intraperitoneally twice
with a 2-h interval between injections; mice were killed 2 h after the second injection. (A) Brain sections at the level of frontal cortex immunostained with
BrdU antibody showing the injection needle track (arrow). (B) High-magnification images showing BrdU-labeled cells in the subventricular zone of
representative L- NAME- and PBS-treated mice. (C) Numbers of BrdU-positive cells in the subventricular zone were quantified (see Materials and methods).
Values are the means and SD (5 PBS- and 5 L-NAME-treated mice). *, P  0.05; **, P  0.01 (paired t tests).
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nal circuits in the adult brain. For example, nNOS expres-
sion and nitric oxide signaling are required for NGF-in-
duced neurite outgrowth in PC12 cells (Phung et al., 1999),
the complexity of dendrites in developing motor neurons is
decreased in mice lacking nNOS (Inglis et al., 1998), and
nNOS expression and localization changes in developing
mouse and rat brains in a manner consistent with a role for
nitric oxide in synaptogenesis (Ogilvie et al., 1995). A role
for nitric oxide in long-term potentiation of synaptic trans-
mission in the hippocampus, a presumptive cellular mech-
anism of learning and memory, has been established in a
series of studies (Hawkins et al., 1998). The results of
behavioral studies in which nitric oxide production was
manipulated are also consistent with a role for nitric oxide
in learning and memory (Holcher et al., 1996). Learning
increases BDNF expression in the hippocampus (Hall et al.,
2000) and increases the numbers of nNOS immunoreactive
neurons in the dentate gyrus and frontal cortex of adult rats
(Zhang et al., 1998). In light of recent studies linking neu-
rogenesis to learning and memory (Shors et al., 2001), our
data suggest a possible role for nitric oxide-induced neuro-
genesis in enhanced learning and memory in response to
environmental signals, such as complex environments, that
upregulate BDNF and nitric oxide signaling in the adult
brain.
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